N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-META-HYDROXYPHENYL-L-PARA-TYROSINAMIDE
Compound with spectra: 1 NMR
![N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-META-HYDROXYPHENYL-L-PARA-TYROSINAMIDE](/api/compound/1zD0yeaE74C.png?ph=true&h=300&w=458 "N-[(N-CHLORAMBUCILAMINO)-HEXANOYL]-META-HYDROXYPHENYL-L-PARA-TYROSINAMIDE")
| SpectraBase Compound ID | 1zD0yeaE74C |
|---|---|
| InChI | InChI=1S/C35H44Cl2N4O5/c36-19-22-41(23-20-37)29-15-11-26(12-16-29)6-4-10-33(44)38-21-3-1-2-9-34(45)40-32(24-27-13-17-30(42)18-14-27)35(46)39-28-7-5-8-31(43)25-28/h5,7-8,11-18,25,32,42-43H,1-4,6,9-10,19-24H2,(H,38,44)(H,39,46)(H,40,45)/t32-/m1/s1 |
| InChIKey | QHRUFOAOVRYBGG-JGCGQSQUSA-N |
| Mol Weight | 671.7 g/mol |
| Molecular Formula | C35H44Cl2N4O5 |
| Exact Mass | 670.268876 g/mol |
| Enantiomer InChIKey | QHRUFOAOVRYBGG-YTTGMZPUSA-N |
| Racemate InChIKey | QHRUFOAOVRYBGG-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | ACETONE-D6 |
N-[(N-CHLORAMBUCILAMINO)-UNDECANOYL]-META-HYDROXYPHENYL-L-PARA-TYROSINAMIDE
4-(N,O-DIACETYL-L-TYROSYL)AMINO-2-IODOBENZOIC ACID
N-[1-benzyl-2-(4-bromo-3-methylanilino)-2-oxoethyl]-4-methylcyclohexanecarboxamide
(S,S)-N-Methyl-N-[N'-[1-[N''-(3,5-dimethylphenyl)carbamyl)-2-phenylethyl]carbamyl]-2-methylpropyl]formamide
VAL-TYR-GLY-HIS, ANGIOTENSIN TETRAPEPTIDE ANALOG
2-Benzothiazolylthioacetyl L-tyrosine hydrazide
ethyl 6-(4-hydroxybenzyl)-2,2-dimethyl-9-[2-(methylsulfanyl)ethyl]-4,7,10-trioxo-3-oxa-5,8,11-triazatridecan-13-oate
pentanoic acid, 5-amino-4-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]-1-oxo-3-[4-(phenylmethoxy)phenyl]propyl]amino]-5-oxo-, phenylmethyl ester
SPIROIDESIN;(HEX)-(D-HTYR)-(L-HTYR)-(D-PHE)
N-(1-(4-Hydroxybenzyl)-2-[(2E)-2-(1-methylpentylidene)hydrazino]-2-oxoethyl)-3,5-dinitrobenzamide
| Title | Journal or Book | Year |
|---|---|---|
| Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines | Steroids | 2012 |